Interestingly, liraglutide was able to reduce IL-6 levels in adult T1D patients with polyneuropathy in a randomized, double-blinded, controlled study; however, it did not improve established neuropathy [101]. The gene discussed is IL6; the disease is type 1 diabetes mellitus.